The story of Sildenafil presents a complex case for investors in the pharmaceutical sector. While initially a tremendous success, generating billions, the intellectual property lapse and the subsequent entry of cheaper https://escort405039.blogzag.com/85145687/the-little-copyright-and-pharma-a-speculative-bet